Vildanat M 500SR Tab

Composition

Vildagliptin 50 mg + Metformin Hydrochloride 500 mg (Sustained Release)

Uses of Vildanat M 500SR Tab

Type 2 diabetes mellitus (in adults) to improve blood glucose control along with diet and exercise, especially when metformin alone is inadequate

• •Helps lower HbA1c and fasting/post-meal glucose
• •Glucose-dependent action with low hypoglycaemia risk when used without sulfonylurea/insulin
• •Improves insulin sensitivity and reduces hepatic glucose output
• •Convenient sustained-release metformin for prolonged control
• •May improve GI tolerability vs immediate-release metformin in some patients

How it works

Vildagliptin is a DPP-4 inhibitor that increases incretin levels (GLP-1/GIP), enhancing glucose-dependent insulin release and reducing glucagon. Metformin reduces hepatic glucose production and improves insulin sensitivity; the SR form provides prolonged action and may improve gastrointestinal tolerability.

Directions for use

Oral tablet. Usually taken once or twice daily as prescribed, preferably with meals to reduce stomach upset. Swallow whole; do not crush or chew sustained-release tablets. Regularly monitor blood glucose and follow diet/exercise advice.

Side effects

Common side effects of Vildanat M 500SR Tab may include:

• •Nausea
• •